High Tea With Oncolytics Biotech ($oncyf) Ceo Dr. Matthew Coffey The phone rings. It’s an exuberant Matt Coffey, Ph.D,...
Author Archive for: support@thriveagency.com
Oncolytics Makes Good On Promise, Brings New Tumor Response Biomarker To Clinic
support@thriveagency.com, , BioPub, oncolytics, 0Oncolytics Makes Good On Promise, Brings New Tumor Response Biomarker To Clinic Oncolytics Biotech ($ONCY) is today announcing acceptance and...
Why Is Oncolytics ($ONCY) Not Belle Of The Ball? I don’t often write articles for BioPub for a number of reasons;...
Cleveland On $NGEN: Are Nervgen’s Books Really Squeaky Clean?
support@thriveagency.com, , BioPub, nervgen, 1Cleveland On $NGEN: Are Nervgen’s Books Really Squeaky Clean?
Morning Sumatra With Nervgen Co-founder Dr. Harold Punnett
support@thriveagency.com, , BioPub, nervgen, 0Morning Sumatra With Nervgen Co-founder Dr. Harold Punnett By now most readers know at least the base-case scenario about NervGen,...
The Silver Lining Nervgen Playbook. Part 2 Transcribed and Edited for Clarity by Allan Lee, Managing Editor CLEVELAND–On a...
The Silver Lining Nervgen Playbook. Part 1 Before he became a famed MIT professor and AI expert, Marvin Minsky...
The Marker Interviews. I. By Allan Lee And Kss, Md, Phd
support@thriveagency.com, , BioPub, marker, 0The Marker Interviews. I. By Allan Lee And Kss, Md, Phd HOUSTON– History will come to regard the teen years...
What We Saw At The Revolution Field Notes from a Visit To Marker Therapeutics, Houston, TX, and the $MRKR...
The Road To Knowwhere Two weeks ago in San Francisco, our old friend the venerable tech investment banker Pete Conley of Boustead...